ImmunityBio Inc. Common Stock vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $10.64 (market cap $10.51B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.33 (market cap $5.86B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.73% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Super Group (SGHC) Limited Ordinary Shares for 0 Days on average.
| IBRX | SGHC | |
|---|---|---|
Market Cap | $10.51B | $5.86B |
Volume | 10,445,785 | 1,905,788 |
Sector | Health | Consumer Cyclical |
52-Week High | $11.55 | $15.59 |
52-Week Low | $1.98 | $8.52 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $5.41B |
Dividend Yield | — | 1.73% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →